Novel peptide conjugates of two antitubercular drug ca ndidates were s ynthesi s ed a nd cha ra cteri s ed us i ng new tufts i n peptide derivatives (OT14) as carrier moiety. As antitubercular drug ca ndidates two pyridopyrimidine derivatives, TB803 (2-a l lylamino-4-oxopyrido[1,2-a]pyrimidine-3-carbaldehyde) a nd TB820 (4-oxo-2-(pyrroli di n-1-yl )-pyri do[1,2-a ]pyri mi di n-3-ca rba ldehyde) inhibiting vi tal enzyme of Mycobacterium tuberculosis were applied. Membrane affini ty of the compounds TB803 a nd TB820 a nd their peptide conjugates wa s eva l ua ted us i ng experi menta l l i pi d mono -a nd bi l a yer model s . Penetration ability was assessed tensiometrically from La ngmuir monolayer study a nd a pplying quartz crys tal microbalance for the s upported l ipid bilayer (SLB) system. Mi nimal inhibitory concentration (MIC) values remained in a similar micromolar ra nge for both of the conjugates whi l e thei r cel l ul a r upta k e ra te wa s i mproved s i gni fi ca ntl y compa red to the drug ca ndidates. A correlation was found between membrane affinity properties a nd results of in vitro bi ological i nvestiga ti ons . Ana l ysis of physical/structural properties of SLB in contact with bioactive components and vi s ua l i za ti on of the s tructura l cha nge by a tomic-force microscopy (AFM) provi ded i nformation on the type and route of mol ecul a r i ntera cti on of drug cons truction with lipid l ayers. The possible role of electrostatic i nteractions between lipid layer a nd drug ca ndi da tes wa s tes ted in Langmuir-balance experiments using nega ti vel y cha rged l i pi d mi xture (DPPC+DPPG). Es peci a l l y the pepti de conjugates presented i ncreased membrane affinity due to ca tionic cha ra cter of the pepti de s equence s el ected for the conjugate formation. That is supposed to be one reason for the enhanced cellular uptake observed in vitro for MonoMa c6 cel l line. The conjugation of a ntitubercular a gents to a peptidic ca rrier i s a promi s i ng a pproa ch to enha nce membra ne a ffi ni ty, cel l ul a r upta ke ra te a nd in vitro s el ecti vi ty.
Introduction

Tuberculosis (TB) is a bacterial infection mainly caused by Mycobacterium tuberculosis (Mtb).
TB remains a major public health problem worldwide and the first cause of mortality attributable to a single intracellular pathogen. Therefore there is an urgent need to develop new agents, active against the intracellular bacteria. The cellular uptake of the antituberculotics by infected host cells is limited. It is a possible approach to enhance the uptake rate of the antituberculars using peptide carriers [1] . The host cell specific delivery of the active compounds could increase the intracellular concentration [2] . In this study macrophage -as main host cell -specific conjugates were synthesised and characterised [2] [3] [4] [5] [6] .
Tuftsin is a natural tetrapeptide (human: TKPR, canine: TKPK) produced by enzymatic cleavage of the Fc-domain of the heavy chain of IgG [4] . Tuftsin activates the immune system, including macrophages. C. M. Gupta et al. have developed tuftsin-bearing liposomes that not only enhance the host's resistance against a variety of infections but also serve as useful vehicles for the site -specific delivery of drugs in a variety of macrophage-based infections, such as leishmaniasis and TB [7] . A group of sequential oligopeptides based on tuftsin has been developed [5] . The synthetic oligotuftsins consist of tandem pentapeptide repeat units [TKPKG] n (n: 2, 4, 6, 8) derived from the canine tuftsin sequence TKPK extended by a C-terminal Gly [3, 5] . The canine tuftsin TKPK, where arginine residues is replaced by lysine, that has also basic character has similar biological activities like the human tuftsin TKPR [8] . However, the lysine residue in the sequence of TKPK can offer a new functional group for connection of a biologically active compound. With the addition of a glycine residue to the C-terminal of TKPK racemisation free condensation of the fragments can be achieved to form larger oligomers [3] . These compounds are nontoxic, nonimmunogenic, biodegradable, and exhibit tuftsin-like biological properties, e.g. immunostimulatory activity and chemotactic activity on monocytes. The lysine residues in the sequence of oligotuftsins can offer functional groups for connection of a biologically active compound such as antituberculars. New heterotrimer TKPR-
[TKPKG] 2 oligotuftsin derivative (OT14) was applied in this study as carrier and targeting moiety.
Molecular modelling study suggested a flexible structure for oligotuftsins and also demonstrated accessibility of the ε-amino group of each lysine residue [3] . In case of OT14 as new carrier Lys8 and Lys13 were the most accessible out of the five Lys residues to form chemical linkage with antitubercular compound.
Small molecular drug candidates can be identified using the in silico docking method [9] . With this method compounds of a database [10, 11] , that consists millions of moieties, were docked to the dUTPase enzyme (EC 3.6.1.23; Rv2697) [12] , which plays a key role in the metabolism of the bacteria.
dUTPase regulating the extent of uracil incorporation into DNA. Massive uracil incorporation may lead to cell death; dUTPase enzyme has therefore been recognized as a high-potential drug target in mycobacterial disease control. The efficacy of the compounds with in vitro antitubercular activity can be varied by synthetic optimization, so the starting compounds can be converted into drug candidates. After structure -activity studies with best ranked heteroaromatic pyrido-pyrimidine derivatives on virulent Mtb H 37 Rv, two of these new optimized antitubercular compounds (TB803, TB820 [13] ) were conjugated to new oligotuftsin type peptide carrier OT14 through oxime bond.
To get information whether drugs can get through the barriers in living system such as cell membrane or bacterial cell wall is especially important for developments of new drug constructions with enhanced efficiency. Simplified lipid model systems were applied to study the details of membrane affinity of the bioactive compounds. The Langmuir monolayer of lipid molecules is a widely used membrane model due to its well defined and controlled structure as well as versatility in composition [12] [13] [14] [15] [16] [17] [18] [19] . The molecular interaction with dissolved drug component is monitored by the increase of surface pressure allowing to deduce its penetration ability [20] [21] [22] [23] . Furthermore, the lipid layer can be transferred from the water surface to a solid substrate opening the pos sible application of characterisation techniques of solid surfaces [24] [25] [26] .
Supported lipid bilayer (SLB) prepared from phospholipid vesicles [27] [28] [29] was also used as model of cell membranes [30, 31] . Once SLBs are constituted on the quartz crystal microbalance (QCM) sensor surface the sensitive detection of mass change allows to assess the interfacial interactions, the adsorption, desorption processes and membrane integrity [32] [33] [34] . With the aid of atomic force microscopy the results obtained were related to visual observations of the structural change of SLB induced by the interaction with the drug molecules.
In the present work we report on the synthesis of peptide conjugates using new tuftsin type carrier peptide and antitubercular drug candidates which were characterised by their membrane interaction using mono-and bilayer lipid model systems. Those properties were compared to their in vitro behaviour observed in antimicrobial and cytotoxic activity studies as well as the results of cellular uptake measurements.
Experimental Materials
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC, Sigma-Aldrich) was used to form the lipid monolayer in the Langmuir trough and create the lipid bilayer on the sensor surface of QCM.
1,2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC, Sigma-Aldrich) and a negatively charged lipid, 1,2-dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) (DPPG, Sigma-Aldrich) were mixed with 1:3 molar ratio and applied as a second model lipid system to mimic a negatively charged natural bacterial lipid envelope.
Chloroform, dichloromethane (purity ≥ 99.8%) and methanol (purity ≥ 99%) were used for preparing lipid solution and cleaning the Langmuir trough, all solvents were of analytical grade.
Doubly distilled water checked by its conductivity (< 5 mS) and surface tension (72.0 mN/m at (25 ± 0.5) °C) was used for buffer preparation and it was the subphase in the Langmuir balance measurements.
A buffer consisting of 10 mM Tris, 150 mM NaCl and 2 mM CaCl 2 at pH = 7.4 (Sigma-Aldrich) was used for QCM measurements and liposome preparation.
For vesicle preparation, 10 mg POPC powder was first dissolved in 1 mL mixture of chloroform and 5% (V/V) methanol in a glass flask. After 30 min mixing, the organic solvents were evaporated using a rotary evaporator and dried with a vacuum pump for two hours to remove any residual solvents. The dried lipid film was then rehydrated with 10 mL buffer. To prepare unilamellar vesicles, the stock (1.0 g/L) and diluted (0.1 g/L) lipid suspensions were forced through a polycarbonate membrane filter with 100 nm pore size for 31 times each at 30 °C using an Avanti Mini-Extruder (Avanti Polar Lipids, USA) directly before QCM measurements. The hydrodynamic diameter of these particles is (104 ± 7) nm which was determined by dynamic light scattering measurements (products of Sigma-Aldrich) in 1000 mL of deionized water. 24-well and 96-well flat-bottomed plates were the products of Sarstedt Ltd (Hungary).
Synthesis of the peptide conjugates
The TKPR[TKPKG] 2 (OT14) new heterotrimer analogue of the tuftsin sequence was produced on Fmoc-Rink Amide MBHA resin in an automated peptide synthesiser (Syro-I, Biotage, Sweden) using Fmoc/tBu strategy.
TB803 and TB820 compounds were conjugated to the OT14 peptide via oxime ligation. The N ε -4-methyltrityl protecting groups of the side chain of two Lys residues were selectively removed with 2% TFA, 2% TIS in DCM (6 × 5 min) . After the 4-methyltrityl protecting group removal the resin was washed (5 × 1 min DCM) and neutralised (5 x 1 min 10% DIEA in DCM) and free amino groups were reacted with Boc-aminooxyacetic acid. After peptide was removed from the resin with TFA in the presence of scavengers (cleavage mixture: 95% TFA, 2.5% TIS, 2.5% H 2 O), aminooxy-peptide was allowed to react with the TB803 or TB820 aldehyde compounds in solution (2.2 equivalent TB803 or TB820 was added to the peptide in 0.2 M NaOAc/AcOH buffer, pH = 5.0 and DMF 1:1 V/V, the reaction was stirred at room temperature for 16 hours).
Reverse Phase High-Performance Liquid Chromatography (RP-HPLC)
The conjugates were purified on a KNAUER 2501 HPLC system (KNAUER, Germany) using a semipreparative Phenomenex Jupiter C18 column (250 mm × 10 mm) with 10 μm silica (300 Å pore size, Gen-Lab Ltd., Hungary). Linear gradient elution (0-5 min 10% B, 5-75 min 10-80% B) with eluent A (0.1% TFA in water) and eluent B (0.1% TFA in acetonitrile/H 2 O (80:20, V/V)) was used at a flow rate of 4 mL/min. Peaks were detected at 220 nm. Analytical RP-HPLC was performed on an Exformma EX1600 HPLC system (Gen-Lab Ltd., Hungary) using an Agilent Zorbax SB-C18 column (150 mm × 4.6 mm) with 5 μm silica, 100 Å pore size (Kromat Ltd, Hungary) as a stationary phase.
Linear gradient elution (0-10 min 0% B, 10-30 min 0-90% B) was used at a flow rate of 1 mL/min.
Peaks were detected at 220 nm.
Mass Spectrometry (MS)
Electrospray (ESI)-mass spectrometric analysis were carried out on an Esquire 3000+ ion trap mass spectrometer (Bruker Daltonics, Germany). Spectra were acquired in the 50 -2500 m/z range.
Samples were dissolved in a mixture of 0.1% acetic acid in acetonitrile/H 2 O (50:50, V/V) ( Fig. 1 , Table 2 ).
Monolayer studies
The lipid layer measurements were accomplished by a computer controlled KSV MiniMicro Langmuir balance (KSV Instruments, Finland). The trough was mounted on an aluminium base with built-in channels for temperature control of the subphase and enclosed in an environment chamber.
The trough was made of Teflon and the barrier from polyoxymethylene (POM). The experiments were performed at (25 ± 0.5) °C.
Lipids were dissolved in chloroform, and 50 µL of 0.2 g/L solutions were applied by a microsyringe to form monolayer on the water surface. The solvent was allowed to evaporate for 15 min. By two movable barriers the lipid layer was compressed into a dense and symmetric monolayer while the surface pressure and the area were continuously recorded. The su rface pressure was measured by the Wilhelmy method using a chromatography paper sensor (Whatman Chr1).
The lipid monolayer was compressed to a given surface pressure ( The adsorbed mass (Δm) on the sensor surface can be related to changes in resonance frequency (Δf) through the Sauerbrey equation [35] :
where C f corresponds to the sensitivity factor for the crystal (56.6 Hz × µg -1 × cm 2 for a 5 MHz AT-cut quartz crystal at room temperature). Measurements were done in triplicates.
AFM (Atomic Force Microscopy) measurement
Sensor surfaces were investigated by atomic force microscopy (AFM) (Park System, XE-100, South Korea) after QCM measurements to visualize changes in the structure of the lipid membrane following their interaction with the drug candidates. Measurements were performed in air at 25 °C in non-contact mode. The cantilever (NSC15/AlBS, MicroMasch, force constant 40 N/m, 325 kHz resonance frequency) made of Si 3 N 4 has a tip curvature radius less than 10 nm with an Al-coated reflective back side. A scanning rate of 1.0 Hz was used with a scan window of 5 × 5 µm 2 . The images were analysed using the XEI 1.8 program (Park Systems, South Korea) to obtain information on the lipid bilayer and the effect of the interactions with peptides and conjugates.
Evaluation of in vitro antimycobacterial activity on Mycobacterium tuberculosis H 37 Rv
In vitro antimycobacterial activity of the compounds was determined on M. tuberculosis H 37 Rv (ATCC 27294) by serial dilution method in Sula semisynthetic medium [36] , which was prepared inhouse (pH = 6.5). Compounds were added to the medium as DMSO solutions at 10 various doses (range of final concentration was between 0.5 and 100 μg/mL). Minimal inhibitory concentration (MIC) was determined after incubation at 37 °C for 28 days. MIC was the lowest concentration of a compound at which the visible inhibition of the growth of M. tuberculosis H 3 7Rv occurred. In order to confirm growth inhibition, colony forming unit (CFU) was determined by subculturing from the Sula medium onto drug-free Löwenstein−Jensen solid [37] medium Samples were incubated for 28 days.
Experiments were repeated at least two times [2, 5, 12, 13, 38, 39] . All experiments with virulent human pathogen M. tuberculosis H 37 Rv were carried out in a bio-safety level 3 (BL-3) containment area at Korányi National Tuberculosis Hospital (Budapest, Hungary).
Determination of in vitro cytotoxic activity on MonoMac6 cells
MonoMac6 cell cultures (DSMZ no.: ACC 124, Deutsche Sammlung von Mikroorganismen and
Zellkulturen GmbH, Braunschweig, Germany) were maintained in RPMI-1640 medium containing 10% FCS, 2 mM L-glutamine, and 160 μg/mL gentamycin at 37 °C in 5% CO 2 atmosphere. The cells were plated on 96-well plates (10 4 cells/100 μL medium/well) and after 24 h incubation at 37 °C, cells were 
Results and Discussions
New pyridopyrimidine derivatives were defined using in silico docking method [44] prior to chemical optimization based on structure -activity studies [31, 45] . The in vitro antimycobacterial activity of the compounds was characterised by the determination of the minimal inhibitory concentration (MIC) on M. tuberculosis H 37 Rv culture with 4-week exposure period [2] . For further chemical modification a pyrido-pyrimidine derivative (2-allylamino-3-allyliminomethylpyrido[1,2- a]pyrimidin-4-one) was chosen. After structure -activity studies with pyrido-pyrimidines two of these new optimized antitubercular compounds (TB803, TB820 [13] ) were conjugated to a new oligotuftsin derivative heterotimer peptide carrier OT14 through oxime bond (Fig. 1) . We observed that the Lys8 and Lys13 residues were the most accessible out of the five Lys residues of OT14 carrier to form chemical linkage with antitubercular compound. TB803-OT14 and TB820-OT14 conjugates were carefully characterised by mass spectrometry, analytical RP-HPLC and amino acid analysis (data not shown). The compounds exhibited fluorescence when excited at 488 nm enabling their detection in cellular uptake measurements (emission at λ = 550 nm) without additional labelling.
Fig. 1.
Chemical structure of TB803, TB820 compounds, their peptide conjugates, and ESI -MS mass spectra of the conjugates. TB803 and TB820 compounds were conjugated to the peptide carriers via oxime ligation.
Monolayer studies
The membrane affinity of the drug candidates and conjugates was studied in Langmuir-balance experiments, where the adsorption and/or penetration into the lipid layer were detected. POPC and DPPC+DPPG mixture as characteristic components of eukaryotic cell membrane or bacterial cell envelope were chosen to form the lipid monolayers as membrane model.
Surface pressure -area isotherms were recorded for the lipid monolayer systems. The isotherm of POPC shows a gradual change with molecular area and does not present the phase transition typical for DPPC. This shape in connection with the low phase transition temperature (-2 °C) of POPC is in agreement with the previously published results [46, 47] . The DPPC+DPPG mixture conversely shows the distinct states of lipid monolayer characteristic for pure DPPC. The presence of 25 mol% of the anionic DPPG has negligible effect on the phase behaviour of the lipid film however, could greatly influence the interaction with cationic peptides [48] .
Surface pressure of 20 mN/m was selected as starting value of the compressed lipid film for the penetration experiments which is high enough to represent the packing of lipid molecules in the membrane and appropriate value to allow evaluation of the possible differences in the penetration ability of the various components studied.
Increase of surface pressure () was detected as function of the time following the introduction of drug compound into the subphase of lipid monolayer. In the first period after injection a fast increase of the surface pressure was observed. After approximately 5 min the change of surface pressure became smaller. Δ values determined at t = 1 h characterising the penetration ability of the drugs are summarized in Table 1 . Small drug molecules just slightly penetrate into the lipid monolayers. The penetration affinity is significantly increased for the peptide conjugates (TB803-OT14, TB820-OT14), especially when electrostatic interactions with the charged DPPC+DPPG monolayer are effective. The highest membrane affinity was obtained for the TB803-OT14 considering any of the lipid layers.
Bilayer studies
The membrane affinity of the drug candidates and their peptide conjugates were characterised by their interaction with supported lipid bilayers. QCM-R technique was employed to follow the interactions at the SLB -liquid interface. The supported bilayers were prepared in situ in the QCM liquid cell by spreading POPC liposomes on silica coated QCM sensor crystals. Mass changes were detected as changes in the resonance frequency of the sensor quartz crystal. The increased mass of the sensor leads to the decrease of vibrational frequency. In addition to that the QCM-R technique allows for the simultaneous and independent determination of the motional resistance of the sensor which can be used to interpret changes in the structure of the liquid-solid interface. Fig. 2 shows a typical measurement curve. Following the stable baseline (1) liposomes were introduced (2) and after spreading and rupture of liposomes a lipid bilayer was formed (3) . Then the bioactive compound was injected and Δf and ΔR showed the interaction of drug or drug-conjugate with lipid bilayer (4) followed by a rinsing with buffer (5). 
where n is the number of sides in contact with liquid, ω is the angular frequency at resonance, L is the inductance of the unperturbed resonator, ρ q and μ q are the density and shear modulus of quartz.
Similarly the effect of viscous loading on the resonance frequency can be estimated using KanazawaGordon equation [50, 51] 
where f 0 is the resonance frequency of the unloaded crystal.
Considering that the motional resistance is mainly affected by the changes in the viscoelastic properties of the surface layer while mass changes also add to the measured frequency changes, these two equations can be used to estimate the viscous loading contribution in the total frequency.
is calculated using Eq. 2 followed by the estimation of the Δf due to changes in the sensor surface structure and/or environment using Eq. 3. Subtracting this contribution from the total frequency change the mass change contribution of the frequency ( Δf 5,m ) can be calculated. These calculated values are also presented in Table 1 .
Increased resistance value is the signal of the expansion of the surface layer, which becomes looser. Accordingly, a decrease in the motional resistance indicates the layer becoming denser, more rigid.
For the various drug candidates a definite distinction can be made based on the exhibited motional resistance changes depending on the structure of the molecules. For the small drug candidates the change in motional resistance is close to zero indicating no significant variation in the viscous property of the layer. The peptide conjugates of the two drug molecules however, present marked increase of motional resistance. That can be considered as the viscoelastic changes at the interface due to the interaction with SLB, especially for TB803-OT14. Considering these results the peptide conjugates are able to loosen the lipid bilayer increasing the viscosity of the surface layer.
Simultaneously, the calculated components of the frequency change responsible for mass change (∆f 5,m ) are positive except for the case of TB803-OT14. That small mass reduction indicates that the molecules interact slightly with the lipid membrane, a partial displacement of SLB can occur.
On the contrary ∆f 5,m is a negative value indicating mass increase for drug conjugate TB803-OT14. This strong attraction is in accordance with the highest membrane affinity of that conjugate obtained in lipid monolayer experiment.
Morphology studies of the lipid layers using AFM could help to understand the changes observed during the QCM measurements. Representative AFM topography images of the different systems are shown in Fig. 4 .
AFM studies confirm that the lipid membranes remain almost intact following the interaction with TB820 (Fig. 4. B) and TB803, only small increase in surface roughness could be observed when comparing pictures with those of pure POPC membrane (Fig. 4. A) . That can be related to the limited disturbance of SLB by the slight interaction. AFM image of the lipid layer following interaction with the TB803-conjugate revealed that only an increase in surface roughness can be detected along with some small sized (5-10 nm high) aggregates (Fig. 4. C) . This is consistent with the QCM results where a significant drop in resonant frequency corresponds with the addition of mass onto the lipid layer.
In the case of TB820-OT14 a considerably different morphology was observed. Although there are only small mass changes during the binding process the structure of lipid bilayer is drastically changed. This is visualized in AFM in Fig. 4 . D. The uniform bilayer structure is destroyed. The main feature of these images is the presence of large aggregates while parts of the bilayer are still observable. If we calculate the total volume of these aggregates it turns out to be the same volume as a continuous POPC bilayer would have. For multiple images this turned out to be consistent within 5% error. This interfacial restructuring is upheld by the QCM results. The presence of the loose aggregates would lead to an increase in the viscous loading as observed while most of the material remained on the surface.
The difference in the behaviour of the two conjugates could be attributed to the structure of the small molecules. TB803 with its allylamine group would have a smaller surface area than TB820 with the pyrrolidine group. This could be the reason for the effect TB820-conjugate had on the POPC membrane. Due to its larger surface area the insertion of the molecule would lead to a more disrupted membrane leading to the eventual destruction of the bilayer structure.
In conclusion two main effects can be distinguished considering the influence of drug interacting with lipid layers (Fig. 5) . In the case of the small molecules a weak interaction is proposed, supported by their low membrane affinity. The presence of the molecules at the interface disturbs the ordered structure of the membrane in some extent which might lead to a loss of small fraction of membrane lipids. In the second case with the peptide conjugates the peptide chains bind to the lipid membrane via electrostatic interactions, disturbing the well ordered membrane structure. The hydrophobic drug parts of the molecules can then penetrate more easily the membrane. Depending on the size of the small molecular drug part the conjugates either disturb or completely destroy the lipid bilayer structure. 
In vitro bioactivity studies Minimal inhibitory concentration (MIC) values of the compounds on M. tuberculosis H 37 Rv
Minimal inhibitory concentration (MIC) of the conjugates, the carrier peptide and the free antituberculars TB803 and TB820 were studied on M. tuberculosis H 37 Rv, which is a human pathogen responsible for the infectious disease of tuberculosis. TB803 and TB820 compounds have outstanding inhibitory effect on the bacterial culture. The TB803-OT14 conjugate exhibited uniquely good activity, but TB820-OT14 effect was excellent. The carrier peptide itself was not effective on bacterial culture.
We observed that the antitubercular activity of the free TB803 and TB820 was essentially preserved after conjugation to peptide carriers through oxime bond (Table 2) . These results suggested the significant in vitro antimycobacterial effect of the compounds remained attractive in the conjugate. 
In vitro cytotoxicity on human MonoMac-6 cells
Determination of the in vitro cytotoxic effect of the compounds was carried out on human monocytic cell line MonoMac6 using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. The IC50 values (the concentration which decreases the viability of the cells to 50% from the maximal viability) were determined from the dose -response curves ( Table 2 ). The MonoMac6 cells are considered as an in vitro model of the host cell macrophages. The selectivity indexes (SI) related to each bacterial strain were determined as a ratio of the IC 50 value for cytotoxic activity to the MIC value ( Table 2 ). The compounds did not influence the cell viability up to 500 μM concentration and they showed good selectivity due to the cytotoxicity (low IC 50 value) on human MonoMac-6 cells (Table 2) .
In vitro cellular uptake profile of the compounds
The cellular uptake of the free TB803, TB820 and their peptide -conjugates was determined by All compounds, TB803 and its conjugate are fluorescent. Minimal internalization was detected for TB803 and TB820 compare to that of the untreated control (Fig. 6 ). Conjugation to OT14 peptide significantly increased cellular uptake of the compounds, the treatment with the conjugates has resulted in the highest intracellular fluorescence intensity of MonoMac-6 cells. Enhanced cellular uptake was performed by conjugation of new in silico identified drug candidates to OT14 tuftsin derivative. Bioactivity of the compounds was investigated in vitro. All compounds have outstanding inhibitory effect on the M. tuberculosis bacterial culture. For the effective treatment of the tuberculosis it is essential for drug candidates to be able to kill intercellular bacteria. Therefore cellular uptake measurements were also performed. The treatment of MonoMac6 cells with the TB803 and TB820 compounds evoked almost the same intracellular fluorescent intensity as that of the untreated control, which means that the uptake rate of the free drug candidates were limited. In contrast, the mean fluorescent intensity was significantly higher after the incubation with the OT14 conjugates. Coupling the compounds to OT14 peptide has resulted in non cytotoxic conjugates, and the intracellular fluorescent intensity of TB803−OT14 and TB820-OT14 conjugates treated cells was higher than that of TB803 and TB820 treated cells. These results are in good correlation with the outcome of the model membrane studies.
